Assertio Reports Fourth Quarter and Full Year 2025 Financial Results Assertio (Nasdaq: ASRT) reported Q4 and full-year 2025 results and issued 2026 guidance. Full-year 2025 net product sales were $117.1M and Adjusted EBITDA was $22.7M. Rolvedon sales totaled $68.2M in 2025. Cash and short-term investments were $63.4M at year-end. For 2026 the company expects Net Product Sales $110M–$125M and Adjusted EBITDA $28M–$40M.Q4 trends included a Rolvedon quarter‑end sell‑in that reduced Q4 Rolvedon sales and working capital variability into early 2026.

#ASRT Assertio Reports Fourth Quarter and Full Year 2025 Financial Results

www.stocktitan.net/news/ASRT/assertio-repor...

New week, new races! 🏎️💨 Shaking off the rust in ASRT & TSR before the @waglesports.bsky.social event this weekend!

🎮 Tue/Wed @ 4PM ET: Community Racing (Join me!)
🏆 Sat/Sun @ 4PM ET: WAGL Event!

Let’s see if I’ve still got it! 🦔

#TSR #ASRT #SonicTheHedgehog #Twitch #YouTube #SEGA

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial Assertio Holdings, Inc. today announced that results of a clinical trial investigating a novel dosing schedule of Rolvedon ® injection have been peer reviewed and published in The Oncologist. In the study of patients with early-stage breast cancer, Rolvedon, when administered on the same day as TC chemotherapy demonstrated an effective neutrophil...

#ASRT Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

www.stocktitan.net/news/ASRT/assertio-annou...

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split Assertio (NASDAQ: ASRT) filed a certificate amendment on December 19 to implement a 1-for-15 reverse stock split of its common stock, effective 12:01 a.m. ET on December 26, 2025. Trading will be on a split-adjusted basis when markets open December 26, 2025, and the ticker ASRT will remain unchanged. The new CUSIP will be 04546C 304. The company said the reverse split aims to maintain its Nasdaq listing and support commercial progress around Rolvedon. Proportionate adjustments will be made to the conversion rate of the company’s 6.5% Convertible Senior Notes due 2027 and to shares authorized/reserved under equity plans and outstanding awards. No fractional shares will be issued; fractional entitlements will be paid in cash based on the December 24, 2025 Nasdaq closing price. Continental Stock Transfer & Trust will act as exchange agent.

#ASRT Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

www.stocktitan.net/news/ASRT/assertio-holdi...

Two weeks ago I made this oilpainting during a 6 hour session with good friends.
I tried to be precise and loose at the same time and I enjoyed it a lot. this time!
The model was Donika Ilieva
Oilpaint on panel - 50 x 38,5 cm.
#asrt #oilpainting

Assertio Reports Third Quarter 2025 Financial Results Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the third quarter ended September 30, 2025.. Rolvedon net product sales were $38.6 million for the third quarter of 2025, up from $15.0 million in the...

#ASRT Assertio Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/ASRT/assertio-repor...

A big thank you to everyone who joined our workshops at #ASRT!

If you didn’t get a chance to attend or want to dive deeper into how SGRT is advancing radiation therapy, come see us at #ASTRO25, booth 1925 for live demos.

🚦 Engines ON in 30 mins!

The WAGL Finals are almost here — grab snacks, buckle up, and get ready for chaos! 🏆

📺 twitch.tv/TailsThePrower71

#SEGA #SonicRacing #SonicTheHedgehog #ESports #TSR #ASRT #Twitch #YouTube

WAGL Championship Races! Tomorrow! I hope to see you there! 4 PM ET

twitch.tv/TailsThePrower71 or YouTube.com/@TailsThePrower71

#Twitch #YouTube #ESports #SEGA #SonicTheHedgehog #SonicRacing #ASRT #TSR

🔥🏁 CHAMPIONSHIP TIME! 🏁🔥

Tomorrow at 4 PM ET we crown the WAGL Season Champion!

Two games. One winner. Endless chaos. 👑

📺 twitch.tv/TailsThePrower71 — Be there!

#SEGA #SonicTheHedgehog #ASRT #TSR #SonicRacing #Twitch #YouTube #ESports

First-Ever Real-World Study: How Sympazan Oral Film Treats Severe Childhood Epilepsy Patients at 13.6 Years Study of 181 epilepsy patients, including 29 LGS cases, reveals Sympazan oral film effectiveness. LGS patients averaged 13.6 years vs 21.1 for general epilepsy group. Data presented at ANA2025.

#ASRT Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

www.stocktitan.net/news/ASRT/assertio-prese...

sonic the hedgehog is sitting in a red and white car in a video game . ALT: sonic the hedgehog is sitting in a red and white car in a video game .

🚦 Sonic Racing Week – Round 2!
LIVE now with TSR + ASRT 🚗💨
Let’s race! 🏁
🔴 twitch.tv/TailsThePrower71 or YouTube.com/@TailsThePrower71

#SEGA #SonicTheHedgehog #TSR #ASRT #RacingWeek #Twitch #YouTube

Here at #CURadiology we're hosting #ASRT approved #CME coming up on Sept 13 & 14th!
**Share with your #MRItechs as there is also the opportunity to attend virtually! ⬇️⬇️⬇️
medschool.cuanschutz.edu/radiology/ev...
#RadEd #HotTopicsinMRI2025

TailsThePrower71 - Twitch Hi! Welcome to the workshop! Thanks for dropping in. I’m a Sonic / Variety / Storm Spotter streamer who loves Tails. I’m a legally blind streamer so if you’re wondering why I wear big glasses, that’s ...

Here we go! The green flag waves in about 45 minutes! Join @tailstheprower71.bsky.social on his #Twitch or #YouTube channels for some racing action! twitch.tv/TailsTheProw... #ASRT #TSR #SEGA #SonicTheHedgehog

a dog looking at its reflection in a mirror on a wooden floor ALT: a dog looking at its reflection in a mirror on a wooden floor

Friday, I've got a @waglesports.bsky.social event happening at 3 PM ET where I'll be hosting Daytime tracks and letting the wheel of destiny decide if we'll be racing on standard or mirrored tracks in #TSR and #ASRT. Cya then!

Assertio Q2 Earnings Show Record Rolvedon Growth, $98M Cash Position as Strategic Shift Takes Hold Discover Assertio's Q2 performance: Core products hit new milestones, cash position strengthens to $98M, and transformation strategy yields early results. See full metrics.

#ASRT Assertio Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/ASRT/assertio-repor...

Explore the Estimize calendar to see who’s reporting, uncover the latest #consensus, and test your forecasting skills by adding your own #EPS and #Revenue estimates: ▶️ tinyurl.com/mub6yvkh: #AAP, #AMAT, #AMC, #ASRT, #COHR, #CSCO, #DDD, #DE, #GPRO, #HRB, #JD, #MNDY, #MSGS, #ONON, #PLUG, #PXLW, #SE

What's that noise?!? MRI machines can get quite loud, enough to cause damage, which is why hearing protection is so important for our patients #mrsafetyweek #asrt

The ONLY way to pass the time in traffic on a family road trip! #ASRT

put some vocaloid music on autoplay and somehow instinctively knew i got jumpscared by zako despite having never listened to it before

[ #SteamDeck #SonicAndAllStarsRacingTransformed #ASRT #Sonic #SonicTheHedgehog #SuperMonkeyBall ]

Reveal Estimize Consensus and add your #estimates to the following companies reporting #earnings this week: ▶️ tinyurl.com/4fvcmycd
#AMAT, #ASRT, #BABA, #CSCO, #CSIQ, #CYBR, #DE, #FOXA, #GPRO, #JACK, #JD, #MNDY, #ONON, #SLAB, #TME, #TTWO, #UAA, #WMT
#EarningsSeason #Finance #EPS #Revenue

Assertio Reports First Quarter 2025 Financial Results Assertio Holdings (NASDAQ: ASRT) reported Q1 2025 financial results with total net product sales of $26.0 million, down from $31.9 million in Q1 2024. The company posted a net loss of $13.5 million ($0.14 per share) compared to a loss of $4.5 million ($0.05 per share) in the prior year quarter. Rolvedon sales reached $13.1 million, while Indocin contributed $5.5 million.The company's transformation strategy focuses on reducing legal exposure, simplifying corporate structure, prioritizing growth assets, and pursuing strategic transactions. Notable achievements include settling multiple legal matters and transferring Assertio Therapeutics subsidiary to ATIH Industries. The company maintained a strong balance sheet with $87.3 million in cash and equivalents and $40.0 million in debt as of March 31, 2025.

#ASRT Assertio Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/ASRT/assertio-repor...

🍪🍩Cookie ChUwUnky🍩🍪

" What do you mean you don't want a Chunky cookie?! "

Would you pull for me if I were a Cookie in @CRKingdomEN

[Art by @scremlin.bsky.social ]

#Vtubers #cookierunkingdom #VtubersUprising #asrt #artmeme #artist #fanart

And I'll be streaming my perspective over on my #Twitch channel and #YouTube channel! 7:30 PM ET today! Let's go racing! #SEGA #SonicTheHedgehog #WAGL #Racing #TSR #ASRT twitch.tv/TailsTheProw... or youtube.com/@TailsThePro...

skull902 Livestream 3-12-25 (w/Silver._.Ness & TailsThePrower71) [WAGL: Mirror Mode] YouTube video by skull902

In just over 30 minutes, racers will be lining up and putting their muscle memory to the ultimate test as they battle to fight the urge to turn left when they need to go right! Join us! #TSR #ASRT #SEGA #SonicTheHedgehog www.youtube.com/live/7_2NAAI...

Assertio Delivers $120.8M Annual Revenue, Eyes Transformational 2025 Growth Assertio ends 2024 with $100M cash position and strong Rolvedon momentum. Strategic acquisitions and revenue growth initiatives signal promising outlook for 2025.

#ASRT Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/ASRT/assertio-repor...

For those who are imaging techs, consider voting in this year’s #ASRT election. Deadline March 4 2025 I’m planning to take a look this weekend while I can. #radtech

#RCIS #ASRT #CCI #cathlab #radiologictechnologist #cardiologist

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study Assertio Holdings (NASDAQ: ASRT) announced results from a clinical trial evaluating Rolvedon® (eflapegrastim-xnst) injection when administered on the same day as chemotherapy for early stage breast cancer patients. The open-label, single-arm study, conducted across 13 US sites, demonstrated that Rolvedon, when given 30 minutes post-chemotherapy, achieved 1.8 days to neutrophil count recovery with a 2% febrile neutropenia rate. Notably, no patients required hospitalization for febrile neutropenia, and no new safety concerns were identified. The results were presented at the San Antonio Breast Cancer Symposium.

#ASRT Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

www.stocktitan.net/news/ASRT/assertio-annou...

#ASRT Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

www.stocktitan.net/news/ASRT/buxton-helmsle...